Additionally, IL15 has the potential to bind with IL15Rα on cancer cells, promoting their proliferation and migration independently of IL15Rβ/γc,[7] thus counteracting its immunological anti‐tumor efficacy. This evidence concerns the gene IL2RB and neoplasm.